Almirall, S.A.

Altı ay boyunca karlılık: -1.78%
Temettü getirisi: 2.22%
Sektör: Healthcare

9.01 $

0 $ 0%
9.01 $
9.51 $

paper.min_max_per_year

Promosyon programı Almirall, S.A.

Temel parametreler

Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
2.22
Дивиденд ао
0.1808
Сайт

Seviye

Hafife alma
İsim Anlam Seviye
P/S 1.89 7
P/BV 1.25 9
P/E 183.69 1
Yeterlik
İsim Anlam Seviye
ROA 0.4465 1
ROE 0.7216 1
ROIC 0 0
Temettüler
İsim Anlam Seviye
Temettü getirisi 2.22 5.55
DSI 0.7857 7.86
Ortalama temettü büyümesi -212.22 0
Görev
İsim Anlam Seviye
Debt/EBITDA 2.35 6
Debt/Ratio 0.1706 10
Debt/Equity 0.6059 9
Büyüme dürtüsü
İsim Anlam Seviye
Hasılat, % -21.68 0
Ebitda, % -1.25 0
EPS, % -85.15 0

paper.price.prices

Fiyat Common.min. Common.max. Değiştirmek paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 9.01 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 9.01 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 9.01 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.90d 9.01 $ 9.01 $ 9.01 $ 0 % 0 % 0 %
common.calendar.number_days.180d 9.17 $ 9.01 $ 9.17 $ -1.78 % 0 % 0 %
common.calendar.number_days.1y 9.51 $ 9.01 $ 9.51 $ -5.26 % 0 % 0 %
common.calendar.number_days.3y 15.3 $ 8.85 $ 10.18 $ -41.11 % 0 % 0 %
common.calendar.number_days.5y 8.85 $ 8.85 $ 15.3 $ +101.81 % 0 % 0 %
common.calendar.number_days.10y 8.85 $ 8.85 $ 21.36 $ +101.81 % 0 % 0 %
common.calendar.number_days.ytd 9.17 $ 9.01 $ 9.17 $ -1.78 % 0 % 0 %

Ana sahipler

Benzer şirketler



Şirket yönetimi

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Carlos Gallardo Piqué CEO, President, Member of Management Board & Chairman of the Board 53.55k 1972 (53 yıl)
Mr. Michael McClellan CFO & Member of Management Board N/A 1972 (53 yıl)
Mr. Eloi Crespo Cervera Chief Industrial Operations Officer & Member of Management Board N/A
Mr. Esteve Conesa Panicot Chief People & Culture Officer and Member of Management Board N/A
Dr. Volker Koscielny Chief Medical Officer & Member of Management Board N/A
Dr. Karl Ziegelbauer Chief Scientific Officer & Member of Management Board N/A
Mr. Paolo Cionini Chief Commercial Officer Europe & International and Member of Management Board N/A
Ms. Isabel Cristina Gomes Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board N/A
Ms. Mercedes Diz Lopez Chief Marketing Officer & Member of Management Board N/A
Mr. Pablo Divasson del Fraile Senior Director of Investor Relations N/A

Şirket bilgileri

Adres: Spain, Barcelona, Ronda General Mitre. 151 - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.almirall.com

Şirket hakkında Almirall, S.A.

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.